What does the evidence say about Sage Sleep Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Sage Sleep Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Given the exploratory nature of this study, we used a significance threshold of p P 0.001), whereas 8-hydroxy-2'-deoxyguanosine levels decreased over time.ConclusionsAmong active duty service members with chronic pain, changes in physical function and sleep-related function were associated with changes in oxidative stress. [Snow TJ (2026); evidence level 2] - ObjectiveThis study aimed to evaluate the potential utility of 8-hydroxy-2'-deoxyguanosine as a biomarker for pain-related functional outcomes.MethodsThis is a secondary analysis of a pragmatic clinical trial that recruited active duty service members with chronic pain. [Snow TJ (2026); evidence level 2] - Participants underwent a 6-week interdisciplinary pain management program and completed measures of sleep-related function and physical function, including objective measures of treadmill, lift, and carry battery. [Snow TJ (2026); evidence level 2] - Background Insomnia during pregnancy is a modifiable risk factor for depression. [Felder JN (2026); evidence level 2] - Research in nonpregnant populations and preliminary findings in a pregnant population suggest that targeting insomnia with digital cognitive behavioral therapy for insomnia (CBT-I) may prevent depression. [Felder JN (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.